util
onestep
multiplex
revers
transcriptionpcr
rtpcr
luminex
xmap
technolog
develop
respiratori
multiplex
liquidchip
assay
rmla
china
middl
east
respiratori
syndrom
coronaviru
merscov
perform
rmla
evalu
compar
realtim
rtpcr
detect
data
clinic
specimen
show
rmla
diagnost
sensit
flua
flub
rsv
mpv
data
merscov
due
lack
posit
specimen
data
analyt
sensit
show
detect
limit
rmla
assay
viral
rna
copi
per
flua
flub
merscov
approxim
realtim
rtpcr
assay
valu
mpv
rsv
lower
realtim
rtpcr
respect
result
indic
rmla
sensit
specif
detect
tool
compar
realtim
rtpcr
especi
suitabl
highthroughput
detect
respiratori
specimen
human
respiratori
tract
infect
mostli
caus
respiratori
virus
give
rise
consider
socioeconom
burden
medic
care
social
product
due
signific
morbid
unfortun
respiratori
virus
variou
clinic
symptom
similar
almost
imposs
distinguish
clinic
therefor
rapid
sensit
specif
multitarget
assay
detect
major
common
respiratori
virus
desir
addit
rapid
accur
diagnosi
import
adopt
earli
antivir
treatment
prevent
nosocomi
spread
decreas
stay
durat
reduc
patient
manag
cost
tradit
respiratori
viral
infect
diagnos
cell
cultur
rapid
antigenantibodi
test
direct
fluoresc
assay
howev
timeconsum
unabl
give
earli
diagnosi
mani
studi
molecular
diagnost
assay
demonstr
superior
sensit
convent
assay
accept
new
gold
standard
particular
realtim
pcrrtpcr
show
signific
superior
due
higher
sensit
shorter
turnaround
time
limit
multiplex
capac
realtim
pcr
disabl
detect
target
clinic
specimen
one
assay
simultan
flexibl
multianalyt
profil
xmap
technolog
develop
luminex
corpor
integr
flow
cytometri
encod
microspher
laser
digit
signal
process
offer
molecular
diagnost
platform
simultan
highthroughput
multiplex
detect
target
protein
nucleic
acid
studi
approv
us
fda
clinic
diagnosi
use
variou
applic
sever
assay
kit
base
xmap
technolog
develop
nucleic
acid
detect
respiratori
virus
still
need
improv
exploit
new
emerg
respiratori
virus
influenza
pandem
viru
avian
influenza
viru
middl
east
respiratori
syndrom
coronaviru
merscov
etc
studi
onestep
multiplex
revers
transcriptionpcr
rtpcr
luminex
xmap
technolog
util
develop
respiratori
multiplex
liquichip
assay
rmla
detect
common
respiratori
virus
jiax
includ
influenza
viru
type
flua
b
flub
parainfluenza
viru
type
respiratori
syncyti
viru
rsv
human
metapneumoviru
mpv
well
potenti
threaten
viru
merscov
merscov
includ
target
rmla
consid
outbreak
mer
south
korea
particular
geograph
locat
jiax
north
citi
zhejiang
provinc
near
shanghai
korea
perform
rmla
evalu
compar
relev
realtim
rtpcr
clinic
specimen
respiratori
tract
infect
patient
synthet
standard
viral
gene
sequenc
analyt
sensit
luminexbas
rmla
multiplex
realtim
rtpcr
assay
develop
studi
assess
test
duplic
serial
dilut
posit
standard
rang
viral
rna
transcript
target
standard
curv
drawn
log
valu
standard
concentr
versu
mfi
valu
rmla
figur
c
valu
realtim
rtpcr
figur
calcul
curv
preset
cutoff
valu
mention
materi
method
detect
limit
two
assay
determin
copi
per
flua
flub
rsv
mpv
merscov
respect
analyt
perform
two
assay
also
assess
test
posit
control
clinic
specimen
shown
figur
assay
abl
detect
target
virus
cross
signal
observ
order
examin
perform
rmla
assay
mix
infect
coinfect
specimen
two
mixtur
prepar
randomli
posit
control
ie
contain
three
target
respect
test
studi
target
detect
success
interfer
signal
other
result
show
rmla
satisfi
analyt
specif
multiplex
detect
capac
target
virus
newdevelop
rmla
twopanel
multiplex
realtim
rtpcr
assess
diagnost
perform
practic
applic
detect
clinic
specimen
diagnost
sensit
specif
viral
target
determin
use
result
laboratori
diagnosi
inhous
monoplex
realtim
rtpcr
compar
softwar
spss
version
tabl
data
avail
merscov
due
lack
posit
specimen
result
show
rmla
assay
good
diagnost
sensit
flua
n
flub
n
n
rsv
n
mpv
n
approxim
multiplex
realtim
rtpcr
order
observ
diagnost
consist
two
newdevelop
assay
detect
data
reanalyz
spss
tabl
kappa
valu
five
target
suggest
great
consist
diagnost
perform
addit
found
falseneg
specimen
rsv
mpv
rmla
realtim
pcr
result
c
c
valu
specimen
falseneg
result
rang
rsv
valu
rang
mpv
suggest
detect
limit
rmla
two
target
lower
multiplex
realtim
rtpcr
order
learn
perform
assay
hand
other
reproduc
develop
rmla
multiplex
realtim
rtpcr
assay
assess
posit
specimen
target
test
duplic
three
differ
technician
ten
time
three
month
monitor
interassay
variat
merscov
due
lack
posit
specimen
replac
posit
control
rna
transcript
coeffici
variat
cv
n
interassay
flua
flub
rsv
mpv
merscov
rmla
flua
flub
rsv
mpv
merscov
realtim
rtpcr
cv
intraassay
obtain
test
ten
posit
specimen
duplic
target
use
posit
control
merscov
flua
flub
rsv
mpv
merscov
rmla
flua
flub
wwwimpactjournalscomoncotarget
rsv
mpv
merscov
realtim
rtpcr
result
show
reproduc
two
assay
compar
practic
applic
reagent
cost
turnaround
time
develop
rmla
twopanel
multiplex
realtim
rtpcr
list
tabl
realtim
rtpcr
advantag
simultan
target
amplif
analysi
requir
h
min
test
one
plate
two
panel
assay
avail
setup
one
plate
number
test
specimen
less
due
least
well
need
posit
blank
control
rmla
took
least
h
min
test
one
plate
specimen
well
posit
blank
control
due
subsequ
hybrid
luminex
analysi
target
amplif
workload
two
plate
ie
reaction
use
compar
multitarget
throughput
capabl
two
assay
twopanel
multiplex
realtim
rtpcr
need
four
time
spend
h
min
reaction
one
realtim
pcr
instrument
avail
luminexbas
rmla
need
h
min
ordinari
standard
thermocycl
simultan
avail
amplif
feasibl
lab
overal
turnaround
time
rmla
assay
could
shorten
h
min
specimen
need
test
within
clinic
shift
rmla
still
setup
one
technician
run
anoth
plate
anoth
ordinari
thermocycl
easier
costeffect
altern
purchas
run
sever
realtim
instrument
parallel
addit
cost
analysi
base
reagent
price
china
obvious
higher
us
especi
luminex
bead
report
total
reagent
cost
luminex
xmap
analysi
per
test
per
test
threepanel
duplex
realtim
rtpcr
detect
six
target
studi
develop
two
multiplex
assay
luminexbas
rmla
twopanel
triplex
realtim
rtpcr
six
respiratori
virus
five
common
respiratori
virus
jiax
ie
flua
flub
rsv
mpv
merscov
potenti
threaten
viru
jiax
first
report
describ
luminexbas
laboratorydevelop
assay
design
specif
order
includ
merscov
one
target
sever
commerci
luminexbas
kit
respiratori
virus
avail
xtag
respiratori
viru
panel
rvp
xtag
rvp
fast
luminex
corp
multicod
plx
eragen
bioscienc
resplex
ii
kit
qiagen
howev
either
involv
complic
step
includ
mani
past
ten
year
inhous
realtim
pcr
rtpcr
assay
use
lab
diagnosi
surveil
viral
respiratori
tract
ill
show
good
characterist
rapid
simplic
due
advantag
simultan
amplif
analysi
without
postamplif
manipul
howev
primer
probe
provid
provinci
cdc
state
cdc
design
specif
individu
target
inhous
assay
lab
diagnosi
mostli
monoplex
although
multiplex
realtim
rtpcr
also
use
work
limit
multiplex
throughput
capac
becam
obviou
shortcom
due
limit
fluoresc
channel
realtim
instrument
advers
interact
primer
probe
one
reaction
multiplex
realtim
rtpcr
assay
target
divid
two
panel
develop
realtim
rtpcr
assay
two
panel
six
respiratori
virus
studi
make
limit
throughput
capac
detriment
tight
epidem
period
assay
requir
plate
technician
turnaround
time
otherwis
lab
need
buy
machin
parallel
run
larg
number
sampl
within
limit
work
shift
view
fact
rmla
assay
develop
luminex
multiplex
platform
bioplex
multitarget
highthroughput
detect
platform
allow
detect
target
simultan
perform
continu
analysi
plate
queue
bottleneck
multiplex
pcr
luminex
xmap
technolog
nucleotid
analysi
though
still
exist
intract
due
postamplif
analysi
decreas
possibl
interfer
captur
probe
ad
hybrid
step
primer
probe
design
luminex
assay
becom
easier
criterion
probe
size
amplicon
strict
realtim
pcr
howev
product
less
bp
assur
amplif
effici
analyt
sensit
studi
primer
probe
slightli
modifi
share
rmla
realtim
rtpcr
ensur
amplif
effici
sensit
rmla
assay
also
ensur
compar
two
assay
actual
explor
possibl
transplant
realtim
pcr
assay
luminex
xmap
analysi
result
indic
feasibl
cours
may
need
slight
modif
special
luminex
analysi
studi
develop
rmla
assay
multiplex
realtim
pcr
assay
diagnost
sensit
five
target
data
merscov
due
posit
specimen
cross
reaction
found
obviou
differ
also
found
fact
great
consist
diagnost
perform
present
detect
clinic
specimen
accord
rate
kappa
valu
target
report
similar
result
also
report
luminex
xmap
analysi
target
less
sensit
realtim
pcr
mostli
depend
primer
design
reaction
optim
assay
accord
experi
sensit
analysi
show
detect
limit
rmla
flua
flub
merscov
viral
rna
approxim
realtim
rtpcr
rmla
mpv
rsv
lower
realtim
rtpcr
respect
detect
limit
rmla
six
target
could
cutoff
rmla
set
three
time
blank
control
recommend
ac
commite
environment
improv
result
indic
overal
perform
rmla
compar
realtim
rtpcr
suggest
analyt
sensit
rmla
two
target
rsv
mpv
may
higher
realtim
rtpcr
despit
confirm
statist
data
diagnosi
technic
luminex
xmap
analysi
higher
sensit
specif
realtim
pcr
sinc
liquidphas
hybrid
amplif
decreas
background
interfer
twofluoresc
detect
increas
specif
studi
believ
make
rmla
assay
better
improv
sensit
specif
improv
asymmetr
multiplex
pcr
adopt
protocol
differenti
cycl
condit
base
temperatur
differenti
primer
design
extra
exonucleas
ad
elimin
residu
primer
hybrid
overal
turnaround
time
assay
may
increas
littl
less
minut
addit
reaction
volum
amplif
adjust
contain
viral
rna
templat
product
use
hybrid
amplif
hybrid
analysi
rmla
handl
one
plate
make
assay
conveni
econom
greatli
reduc
probabl
carryov
contamin
preand
postamplif
step
howev
could
next
work
though
done
yet
larg
number
data
base
establish
research
program
obtain
line
studi
object
conclus
newdevelop
realtim
rtpcr
common
respiratori
virus
suitabl
emerg
detect
small
number
specimen
due
advantag
rapid
simplic
develop
luminexbas
rmla
great
sensit
specif
compar
realtim
rtpcr
higher
throughput
capabl
run
larg
number
specimen
simultan
significantli
reduc
cost
furthermor
due
luminex
platform
flexibl
rmla
expand
includ
respiratori
pathogen
target
meet
local
season
emerg
chang
respiratori
infecti
diseas
wwwimpactjournalscomoncotarget
inform
consent
obtain
particip
studi
conduct
studi
procedur
approv
jiax
municip
center
diseas
control
prevent
jiax
cdc
carri
accord
biosafeti
ethic
standard
institut
nation
research
committe
relev
law
regul
peopl
republ
china
total
respiratori
specimen
mainli
specimen
submit
jiax
cdc
hospit
jiax
partial
zhejiang
provinci
center
diseas
control
prevent
zhejiang
cdc
specimen
mostli
nasopharyng
swab
small
number
tracheal
aspir
bronchoalveolar
lavag
collect
viral
transport
medium
store
test
inhous
realtim
rtpcr
monoplex
accord
relev
diagnost
criteria
respiratori
tract
infect
use
primer
probe
provid
zhejiang
cdc
chines
cdc
synthes
accord
sequenc
addit
posit
control
target
virus
tabl
prepar
synthes
target
dna
transcrib
rna
target
dna
synthes
shanghai
sangon
biotech
co
ltd
sangon
rna
transcript
perform
megascript
rnai
kit
catalog
ambion
usa
purif
concentr
use
magmax
viral
rna
isol
kit
catalog
ambion
usa
kingfish
flex
system
thermo
fisher
scientif
inc
usa
vitro
rna
transcript
quantifi
nanodrop
microspectrophotomet
thermo
fisher
scientif
inc
usa
adjust
copi
per
use
easi
dilut
realtim
pcr
cat
takara
china
dalian
origin
quantif
standard
studi
dilut
contain
viral
rna
transcript
use
posit
control
serial
dilut
use
determin
analyt
sensit
follow
assay
store
analysi
specimen
vortex
resuspend
viral
rna
extract
specimen
use
extract
viral
rna
use
magmax
viral
rna
isol
kit
kingfish
flex
system
accord
manufactur
recommend
viral
rna
extract
collect
store
use
addit
flua
posit
control
fluapc
contain
flua
rna
transcript
ad
extract
procedur
order
monitor
rna
extract
effici
compar
concentr
extract
primer
taqman
probe
captur
probe
use
studi
list
tabl
aim
flua
rsv
mpv
improv
redesign
lab
target
assay
includ
new
emerg
virus
flua
target
includ
influenza
viru
subtyp
pdm
rsv
target
includ
rsv
group
b
primer
taqman
probe
flub
merscov
chang
respect
sequenc
recommend
chines
nation
influenza
center
cnic
world
health
organ
forward
primer
revers
primer
taqman
probe
modifi
forward
primer
f
synthes
sangon
captur
probe
p
coupl
fluorescentencod
microspher
bead
linker
use
luminexbas
rmla
assay
design
lab
synthes
shanghai
tellgen
life
scienc
co
ltd
tellgen
one
step
multiplex
realtim
rtpcr
assay
develop
lab
use
takara
one
step
rtpcr
kit
cat
divid
panel
flua
flub
panel
rsv
mpv
merscov
due
channel
avail
detect
touch
realtim
pcr
system
biorad
laboratori
inc
usa
final
mixtur
reaction
contain
viral
rna
extract
optim
concentr
primer
f
r
taqman
probe
tabl
panel
realtim
rtpcr
assay
perform
condit
cycl
qualit
result
assay
determin
follow
threshold
cycl
valu
c
posit
amplif
c
consid
invalid
amplif
neg
c
reserv
still
rang
redo
consid
posit
averag
c
valu
determin
standard
dilut
sampl
two
replic
detect
limit
assay
target
estim
standard
curv
cutoff
point
c
valu
valu
set
studi
multiplex
rtpcr
target
includ
flua
flub
rsv
mpv
merscov
perform
takara
one
step
primescript
rtpcr
kit
reaction
mixtur
contain
viral
rna
extract
optim
concentr
biotinmodifi
forward
primer
f
revers
primer
r
tabl
use
sequenc
realtim
rtpcr
assay
describ
amplif
biotinlabel
pcr
product
reaction
ad
work
bead
mixtur
prepar
temporarili
contain
bead
coupl
captur
probe
target
follow
hybrid
min
min
touch
realtim
pcr
system
work
report
solut
ml
streptavidinphycoerythrin
ad
mixtur
follow
incub
min
origin
bead
solut
target
origin
sape
report
solut
tetramethyl
ammonium
chlorid
tmac
hybrid
buffer
dilut
provid
tellgen
end
final
volum
mixtur
analyz
bioplex
system
biorad
laboratori
inc
usa
median
fluoresc
intens
mfi
least
bead
report
bead
set
averag
mfi
valu
determin
standard
dilut
sampl
duplic
cutoff
valu
posit
result
set
five
time
background
mfi
